Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT07712640
PHASE1

A Study to Investigate the Relative Bioavailability of 2 Tablet Formulations and the Effect of Food on the Pharmacokinetics of BGB-58067 in Healthy Participants

Sponsor: BeOne Medicines

View on ClinicalTrials.gov

Summary

This study is being done to understand how the body processes 2 different tablet formulations of the study drug (BGB-58067) and how food intake influences the processing of the study drug by the body.

Official title: A Phase 1, Single Dose, Open-label, Randomized 4-Period, 4-Sequence Crossover Study to Assess the Relative Bioavailability of Two Tablet Formulations of BGB-58067 and the Effect of Food on the Pharmacokinetics of a Single Oral Dose of BGB-58067 Administered Simultaneously to Healthy Adult Participants

Key Details

Gender

All

Age Range

18 Years - 65 Years

Study Type

INTERVENTIONAL

Enrollment

32

Start Date

2026-07-21

Completion Date

2028-07-01

Last Updated

2026-08-10

Healthy Volunteers

Yes

Interventions

DRUG

BGB-58067 Tablet (F-01 Formulation)

Administered orally

DRUG

BGB-58067 Tablet (F-02 Formulation)

Administered orally

Locations (1)

Cmax Clinical Research

Adelaide, South Australia, Australia